Form D LY-0503 Fund III, a seri
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form SC TO-I TriSalus Life Sciences, Filed by: TriSalus Life Sciences, Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934
TRISALUS LIFE SCIENCES, INC.
(Name of Subject Company and Filing Persons (Issuer))
Warrants to Acquire Shares of Common Stock (Title of Class of Securities)
89680M119 (CUSIP Number of Class of Securities)
Mary Szela
Chief Executive Officer
6272 W. 91st Ave.
Form FWP Seaport Entertainment Filed by: Seaport Entertainment Group Inc.
Free Writing Prospectus dated May 24, 2024Relating to Preliminary Prospectus dated May 23, 2024Filed Pursuant to Rule 433 under the Securities Act of 1933Registration Statement No. 333-279690Seaport Entertainment Group Inc.This free writing prospectus relates to the rights offering expected to be conducted by Seaport Entertainment Group Inc. (the “Company”) and supplements the preliminary prospectus dated May 23, 2024 (the “Preliminary Prospectus”) included in the... (continue reading...)
Form D WL-0227 Fund I, a series
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 6-K Innate Pharma SA For: May 24
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 6-KREPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934Date of report: May 24, 2024Commission File Number: 001-39084Innate Pharma S.A.(Translation of registrant's name into English)Innate Pharma S.A.117 Avenue de Luminy—BP 3019113009 Marseille, France+ 33 (0) 4 30 30 30(Address of principal executive office)Indicate by check mark whether... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K MARINUS PHARMACEUTICALS, For: May 22
-
Form 6-K CHIPMOS TECHNOLOGIES For: May 24
-
Form 6-K PRUDENTIAL PLC For: May 24
-
Form 8-K SDCL EDGE Acquisition For: May 24
-
Form 6-K AUDIOCODES LTD For: May 24
-
Form 6-K GSK plc For: May 24
-
Form 6-K RYANAIR HOLDINGS PLC For: May 24
-
Form D AP-0419 Fund I, a series
-
Form 6-K INDIVIOR PLC For: May 24
-
Form 6-K NIO Inc. For: May 24
-
Form 6-K LexinFintech Holdings For: May 23
-
Form 425 TriSalus Life Sciences, Filed by: TriSalus Life Sciences, Inc.
-
Form 4 Hyzon Motors Inc. For: May 22 Filed by: HORIZON FUEL CELL TECHNOLOGIES PTE LTD
-
Form 8-K TriSalus Life Sciences, For: May 24
-
Form 425 99 Acquisition Group Filed by: 99 Acquisition Group Inc.
-
Form 6-K HUTCHMED (China) Ltd For: May 24
-
Form 6-K AZUL SA For: Jun 30
-
Form SD COHERENT CORP.
-
Form 4 U.S. GOLD CORP. For: May 22 Filed by: Bee George M
-
Form 8-K Finch Therapeutics Group For: May 23
-
Form 6-K KT CORP For: May 24
-
Form C/A VITia, Inc.
-
Form 20-F/A AZUL SA For: Dec 31
-
Form C/A Turant Inc.
-
Form D/A Standard Crypto Flagship
-
Form 6-K Adlai Nortye Ltd. For: May 23
-
Form 424B3 Lotus Technology Inc.
-
Form SD HONDA MOTOR CO LTD
-
Form C BETR Productions, Inc
-
Form EFFECT Inspira Technologies
-
Form 6-K EQUINOR ASA For: May 24
-
Form 6-K Sony Group Corp For: May 24
-
Form S-4 TriSalus Life Sciences,
-
Form 6-K Vertical Aerospace Ltd. For: May 24
-
Form 6-K TELEFONICA BRASIL S.A. For: Jun 30
-
Form 6-K Bilibili Inc. For: May 24
-
Form 8-K Keypath Education Intern For: May 23
-
Form 8-K IOVANCE BIOTHERAPEUTICS, For: May 23
-
Form EFFECT ALPINE IMMUNE SCIENCES,
-
Form EFFECT NEPHROS INC
-
Form 497 BLACKROCK ADVANTAGE GLOB
-
Form S-1 Seaport Entertainment
-
Form 497 BlackRock Funds V
-
Form 6-K The9 LTD For: May 24
-
Form EFFECT Cingulate Inc.
-
Form 497 BLACKROCK GLOBAL ALLOCAT
-
Form EFFECT GE Vernova Inc.
-
Form 497 BLACKROCK ADVANTAGE GLOB
-
Form D Pegasus Tech Ventures
-
Form EFFECT CareDx, Inc.
